SecondLine Treatment Sponsor Oncozyme Pharma Inc. / / /
IndustryTerm
care for metastatic colorectal cancer / de santé et de services / /
MedicalCondition
disease / colorectal cancer / metastatic colorectal cancer / /
MedicalTreatment
chemotherapy / /
Organization
Jewish General Hospital Clinical Research Unit / St-Jérôme Centre / /
Person
Joanne Savard Tél / Jacques Jolivet / Étienne-Le Bel / Félix Couture / Pierre Bédard / Marc-André Rodrigue Tél / Benoît Samson / Richard Létourneau / Petr Kavan / Stéphanie Girard Tél / Annie Beaudoin / Stéphanie Bonin / Maryse Gingras / Robert Zakarian / / /
Position
de santé et de services sociaux de St-Jerome Principal Investigator / CICM Recherche clinique en lutte contre le cancer Principal Investigator / Hôpital Saint-Luc Unité de recherche clinique Principal Investigator / Principal Investigator / Study Coordinator / Québec Hôtel-Dieu de Québec Recherche hémato-oncologie Principal Investigator / Hémato-Oncologie Principal Investigator / /
Primary End Points - To assess the efficacy of OCZ103-OS in prolonging overall survival duration in metastatic colorectal cancer patients treated concurrently with mFOLFOX6 or FOLFIRI - To assess the efficacy of OCZ103-O